Ernesto Doncel-Pérez

Prof. Dr. Ernesto Doncel-Pérez

Neural Regeneration Group, Hospital Nacional de Parapléjicos de Toledo, Toledo, Castille-La Mancha, Spain
orcid
Neuroscientist focused on spinal injury repair and Guillain ...

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
RGRuth C. Galindo
Ruth C. Galindo
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
ZZZorica Zivkovic
Zorica Zivkovic
VNVictoria Naranjo
Victoria Naranjo
CGChristian Gortázar
Christian Gortázar
Jose De La FuenteJose De La Fuente
Jose De La Fuente

30 December 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SASilvia Ayora
Silvia Ayora
BCBegoña Carrasco
Begoña Carrasco
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
RLRudi Lurz
Rudi Lurz
Juan Carlos AlonsoJuan Carlos Alonso
Juan Carlos Alonso
Bacillus subtilisRecU protein is involved in homologous recombination, DNA repair, and chromosome segregation. Purified RecU binds preferentially to three- and four-strand junctions when compared to single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) (≈10- and ≈40-fold lower efficiency, respectively). RecU cleaves mobile four-way junctions but fails to cleave a linear dsDNA with a putative cognate site, a finding consistent with a similar genetic defect observed for genes classified within the ε epistatic group (namelyruvA,recD, andrecU). In the presence of Mg2+, RecU also anneals a circular ssDNA and a homologous linear dsDNA with a ssDNA tail and a linear ssDNA and a homologous supercoiled dsDNA substrate. These results suggest that RecU, which cleaves recombination intermediates with high specificity, might also help in their assembly.

1 January 2003 in Journal of Neurocytology
Verified
Journal Article
Closed access
PDF file
VGVilma Muñetón Goméz
Vilma Muñetón Goméz
SASharon Averill
Sharon Averill
VKVon King
Von King
QYQin Yang
Qin Yang
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
JTJulian Taylor
Julian Taylor

2 March 2015 in Glia
Verified
Journal Article
Closed access
PDF file
MSMaría C. Serrano‐Pérez
María C. Serrano‐Pérez
MFMIRIAM FERNÁNDEZ FERNÁNDEZ
MIRIAM FERNÁNDEZ FERNÁNDEZ
FNFernando Neria
Fernando Neria
MBMónica Berjón‐Otero
Mónica Berjón‐Otero
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
PTPedro Tranque
Pedro Tranque

1 July 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
Inmaculada AranazInmaculada Aranaz
Inmaculada Aranaz
Agatha BastidaAgatha Bastida
Agatha Bastida
JRJulia Revuelta
Julia Revuelta
CCCelia Camacho
Celia Camacho
AFAlfonso Fernández-Mayoralas
Alfonso Fernández-Mayoralas

2 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RGRubén Gil-Gonzalo
Rubén Gil-Gonzalo
DSDaniel Alonzo Durante Salmerón
Daniel Alonzo Durante Salmerón
SPSaeedeh Pouri
Saeedeh Pouri
Ernesto Doncel-PérezErnesto Doncel-Pérez
Ernesto Doncel-Pérez
Andrés R. AlcántaraAndrés R. Alcántara
Andrés R. Alcántara
NANiuris Acosta
Niuris Acosta
Cancer and bacterial infections rank among the most significant global health threats. accounting for roughly 25 million fatalities each year. This statistic underscores the urgent necessity for developing novel drugs, enhancing current treatments, and implementing systems that boost their bioavailability to achieve superior therapeutic outcomes. Liposomes have been recognised as effective carriers; nonetheless, they encounter issues with long-term stability and structural integrity, which limit their pharmaceutical applicability. Chitosomes (chitosan-coated liposomes) are generally a good alternative to solve these issues. This research aims to demonstrate the effective individual encapsulation of ciprofloxacin (antibacterial, hydrophilic) and etoposide (anticancer, hydrophobic), within chitosomes to create more effective drug delivery systems (oral administration for ciprofloxacin, parenteral administration for etoposide). Thus, liposomes and chitosomes were prepared using the thin-film hydration technique and were characterised through ATR-FTIR, Dynamic Light Scattering (DLS), zeta potential, and release profiling. In both cases, the application of chitosomes enhanced long-term stability in size and surface charge. Chitosome-encapsulated ciprofloxacin formulations exhibited a slower and sustained release profile, while the combined effect of etoposide and chitosan showed heightened efficacy against the glioblastoma cell line U373. Therefore, coating liposomes with chitosan improved the encapsulation system’s properties, resulting in a promising method for drug delivery.